EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

Fatemeh Mirzayeh Fashami, Jean-Eric Tarride, Behnam Sadeghirad, Kimia Hariri, Amirreza Peyrovinasab, Mitchell Levine

PharmacoEconomics - Open · 2024-11 · 8 (6) · 823-836

DOI: 10.1007/s41669-024-00511-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PharmacoEconomics - Open, online erschienen am 05.08.2024. Verfasst von Fatemeh Mirzayeh Fashami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Health Research Methodology Graduate Program, McMaster University, 1280 Main St West, Hamilton, ON, Canada. mirzayef@mcmaster.ca. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Health Research Methodology Graduate Program, McMaster University, 1280 Main St West, Hamilton, ON, Canada. mirzayef@mcmaster.ca.
  • Center for Health Economics and Policy Analysis (CHEPA), McMaster University, 1280 Main St West, Hamilton, ON, Canada.
  • Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St Joseph's Healthcare Hamilton, 50 Charlton Ave E, Hamilton, ON, Canada.
  • McMaster Chair in Health Technology Management, McMaster University, 1280 Main St West, Hamilton, ON, Canada.
  • Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main St West, Hamilton, ON, Canada.
  • Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, ON, Canada.

Zitieren

APA

Mirzayeh Fashami, F., Tarride, J. E., Sadeghirad, B., Hariri, K., Peyrovinasab, A., & Levine, M. (2024). Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses. PharmacoEconomics - Open, 8(6), 823-836. https://doi.org/10.1007/s41669-024-00511-9

Vancouver

Mirzayeh Fashami F, Tarride JE, Sadeghirad B, Hariri K, Peyrovinasab A, Levine M. Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses. PharmacoEconomics - Open. 2024;8(6):823-836. doi:10.1007/s41669-024-00511-9

BibTeX
@article{MirzayehFashami2024,
  author = {Mirzayeh Fashami, Fatemeh and Tarride, Jean-Eric and Sadeghirad, Behnam and Hariri, Kimia and Peyrovinasab, Amirreza and Levine, Mitchell},
  title = {Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses},
  journal = {PharmacoEconomics - Open},
  year = {2024},
  volume = {8},
  number = {6},
  pages = {823--836},
  doi = {10.1007/s41669-024-00511-9}
}
Kostenlos starten →